Literature DB >> 31586179

Associations Between Anti-Mullerian Hormone and Cardiometabolic Health in Reproductive Age Women Are Explained by Body Mass Index.

Julie S Rios1, Eleni A Greenwood2, Mary Ellen G Pavone3, Marcelle I Cedars2, Richard S Legro4, Michael P Diamond5, Nanette Santoro6, Fangbai Sun7, Randal D Robinson8, Gregory Christman9, Heping Zhang7, Heather G Huddleston2.   

Abstract

CONTEXT: The relationship between reproductive and cardiometabolic aging is unclear. It is unknown if the relationship differs across different clinical populations.
OBJECTIVE: To determine whether markers of ovarian reserve are associated with cardiometabolic risk in reproductive aged women with unexplained infertility (UI), polycystic ovary syndrome (PCOS), and regularly cycling women (OVA). DESIGN AND
SETTING: Cross-sectional data from 8 US-based academic centers. PARTICIPANTS: Women aged 25-40 from 3 clinical populations: 870 with UI, 640 with PCOS, and 921 community-based OVA. MAIN OUTCOME MEASURES: Multivariable linear regression models were used to relate anti-mullerian hormone (AMH) and antral follicle count with cardiometabolic parameters including body mass index (BMI), waist circumference (WC), fasting glucose and insulin, homeostasis model assessment-insulin resistance (HOMA-IR), lipids, and C-reactive protein.
RESULTS: In age and study site-adjusted models, AMH inversely related to BMI in the UI and OVA groups (P = 0.02 and P < 0.001). Among women with PCOS, AMH inversely related to BMI (P < 0.001), and also to WC (P < 0.001), fasting insulin (P < 0.01), HOMA-IR (P < 0.01), triglycerides (P = 0.04), and C-reactive protein (P < 0.001) and directly related to higher total (P = 0.02), low-density lipoprotein (P < 0.01), and high-density lipoprotein cholesterol (P < 0.01). In OVA, AMH also varied inversely with WC (P < 0.001), fasting insulin (P = 0.02), and HOMA-IR (P = 0.02). Adjustment for BMI eliminated associations in the OVA group but in PCOS, the relationship of AMH to total (P = 0.03) and low-density lipoprotein cholesterol (P = 0.003) remained.
CONCLUSION: Associations observed between AMH and cardiometabolic indices are largely explained by BMI in women with and without PCOS. (J Clin Endocrinol Metab XX: 0-0, 2019). © Endocrine Society 2019. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  anti-mullerian hormone (AMH); cardiometabolic health; cardiovascular risk; ovarian aging; ovarian reserve markers; reproductive aging

Year:  2020        PMID: 31586179      PMCID: PMC7024739          DOI: 10.1210/clinem/dgz012

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  51 in total

1.  Is the plasma anti-Müllerian hormone (AMH) level associated with body weight and metabolic, and hormonal disturbances in women with and without polycystic ovary syndrome?

Authors:  Piotr Skałba; Anna Cygal; Paweł Madej; Anna Dąbkowska-Huć; Jerzy Sikora; Gayane Martirosian; Małgorzata Romanik; Magdalena Olszanecka-Glinianowicz
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2011-07-12       Impact factor: 2.435

2.  Does age at natural menopause affect mortality from ischemic heart disease?

Authors:  B K Jacobsen; S Nilssen; I Heuch; G Kvåle
Journal:  J Clin Epidemiol       Date:  1997-04       Impact factor: 6.437

3.  Cardiovascular risk at age 53 years in relation to the menopause transition and use of hormone replacement therapy: a prospective British birth cohort study.

Authors:  D Kuh; C Langenberg; R Hardy; H Kok; R Cooper; S Butterworth; M E J Wadsworth
Journal:  BJOG       Date:  2005-04       Impact factor: 6.531

4.  Is there any correlation between amh and obesity in premenopausal women?

Authors:  Sezai Sahmay; Taner Usta; Cemal Tamer Erel; Metehan Imamoğlu; Mustafa Küçük; Nil Atakul; Hakan Seyisoğlu
Journal:  Arch Gynecol Obstet       Date:  2012-05-04       Impact factor: 2.344

5.  Depressive symptomatology, psychological stress, and ovarian reserve: a role for psychological factors in ovarian aging?

Authors:  Maria E Bleil; Nancy E Adler; Lauri A Pasch; Barbara Sternfeld; Steven E Gregorich; Mitchell P Rosen; Marcelle I Cedars
Journal:  Menopause       Date:  2012-11       Impact factor: 2.953

6.  The effect of weight loss on anti-Müllerian hormone levels in overweight and obese women with polycystic ovary syndrome and reproductive impairment.

Authors:  R L Thomson; J D Buckley; L J Moran; M Noakes; P M Clifton; R J Norman; G D Brinkworth
Journal:  Hum Reprod       Date:  2009-04-20       Impact factor: 6.918

7.  Does accelerated reproductive aging underlie premenopausal risk for cardiovascular disease?

Authors:  Maria E Bleil; Steven E Gregorich; Daniel McConnell; Mitchell P Rosen; Marcelle I Cedars
Journal:  Menopause       Date:  2013-11       Impact factor: 2.953

8.  Comparison of serum anti-Müllerian hormone levels in normal weight and overweight-obese adolescent patients with polycystic ovary syndrome.

Authors:  Hüseyin Cengiz; Murat Ekin; Hediye Dagdeviren; Şükrü Yildiz; Cihan Kaya; Ammar Kanawati
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2014-06-28       Impact factor: 2.435

9.  Anti-Mullerian hormone and insulin resistance in classic phenotype lean PCOS.

Authors:  Gamze Sinem Caglar; Inci Kahyaoglu; Recai Pabuccu; Selda Demirtas; Rabia Seker
Journal:  Arch Gynecol Obstet       Date:  2013-04-04       Impact factor: 2.344

10.  Anti-Mullerian hormone, inhibin B, and antral follicle count in young women with ovarian failure.

Authors:  Erik A H Knauff; Marinus J C Eijkemans; Cornelius B Lambalk; Marianne J ten Kate-Booij; Annemieke Hoek; Catharina C M Beerendonk; Joop S E Laven; Angelique J Goverde; Frank J M Broekmans; Axel P N Themmen; Frank H de Jong; Bart C J M Fauser
Journal:  J Clin Endocrinol Metab       Date:  2008-12-09       Impact factor: 5.958

View more
  3 in total

1.  Correlation of serum anti-Mullerian hormone with hormonal and environmental parameters in Brazilian climacteric women.

Authors:  Thiago Magalhães Gouvea; Laura Alves Cota E Souza; Angélica Alves Lima
Journal:  Sci Rep       Date:  2022-07-14       Impact factor: 4.996

2.  Correlation Between Serum AMH Levels and Cardiometabolic Indices in PCOS Women.

Authors:  Subarna Mitra; Gautom K Saharia; Saubhagya K Jena
Journal:  Indian J Endocrinol Metab       Date:  2022-02-17

3.  Serum Anti-Müllerian Hormone Levels Were Negatively Associated With Body Fat Percentage in PCOS Patients.

Authors:  Er Luo; Jinxiao Zhang; Jiahui Song; Di Feng; Yaxin Meng; Hongyu Jiang; Da Li; Yuanyuan Fang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-04       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.